UBQLN1 and epilepsy: Zhang et al. reported decreased ubqln1 expression levels in human neocortical samples from TLE patients having at least 4 years of clinical history, and additionally in pilocarpine- and pentylenetetrazole (PTZ)-epilepsy models in rats [10].